Lundbeck voices concern over proposed patent reform in the EU: Could put the industry’s trade secrets at risk

The proposal is one of several that have been making their way through the European legislative mill in Brussels for nearly a year.
According to Lundbeck, new compulsory licensing rules could put the industry's trade secrets at risk. | Photo: Jens Dresling
According to Lundbeck, new compulsory licensing rules could put the industry's trade secrets at risk. | Photo: Jens Dresling

BRUSSELS - Confidential processes and trade secrets could be at risk as the EU negotiates new guidelines for compulsory licensing of medicines in Europe.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Foto: Mike Blake/Reuters/Ritzau Scanpix

    Gilead Sciences CMO to leave early 2025

    For subscribers

    Further reading